MLTX,MoonLake Immunotherapeutics | Healthcare

Healthcare

MLTX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

MoonLake ImmunotherapeuticsMLTX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.

It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases.

The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis.

MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.

Latest News >

Q4 was much better than Q3 in terms of volumes, margins & realisations: Greenpanel Industries

Apr 13, 2021

V Venkatramani, CFO of Greenpanel Industries, in an interview with CNBC-TV18 talked about the impact of the surge in the COVID pandemic, ongoing restrictions on the company's production, demand, and supply.

Mandatory gold hallmarking from June 1: What you should know

Apr 14, 2021

As per the new rules, if jewelry or an artifact made of 14, 18, or 22-carat gold is sold without the BIS hallmark, the jeweler could be penalised five times the cost of the object or imprisoned for up to one year.

Zomato converts itself into public limited company ahead of IPO, may set up own restaurants, hotels

Apr 14, 2021

Ahead of its initial public offer (IPO), foodtech company Zomato has converted itself into a public limited company and has also altered its memorandum of association for the new entity to include the possibility of setting up and run its own hotels and restaurants.

Flipkart set to acquire Cleartrip for $40 million: Report

Apr 14, 2021

The Flipkart-Cleartrip deal, which is likely to value Cleartrip at around $40 million, will be a mix of cash and equity.